Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

FANALE, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.269
EU - Europa 5.507
AS - Asia 4.515
SA - Sud America 712
AF - Africa 116
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 21.140
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.112
SG - Singapore 1.764
RU - Federazione Russa 1.514
CN - Cina 1.135
IT - Italia 1.038
FI - Finlandia 783
DE - Germania 658
BR - Brasile 588
HK - Hong Kong 457
VN - Vietnam 404
GB - Regno Unito 275
PL - Polonia 252
UA - Ucraina 222
FR - Francia 212
IE - Irlanda 149
JP - Giappone 149
SE - Svezia 126
IN - India 118
CA - Canada 96
KR - Corea 94
BD - Bangladesh 65
TR - Turchia 58
RO - Romania 55
IQ - Iraq 53
NL - Olanda 50
BE - Belgio 48
AR - Argentina 38
AT - Austria 37
MX - Messico 37
ES - Italia 28
ZA - Sudafrica 26
CI - Costa d'Avorio 22
IR - Iran 22
UZ - Uzbekistan 20
ID - Indonesia 19
PK - Pakistan 19
EC - Ecuador 16
VE - Venezuela 16
CO - Colombia 15
MA - Marocco 15
AE - Emirati Arabi Uniti 13
MY - Malesia 13
NP - Nepal 13
PH - Filippine 13
KE - Kenya 12
AU - Australia 11
CH - Svizzera 11
CL - Cile 11
KZ - Kazakistan 11
CZ - Repubblica Ceca 10
AZ - Azerbaigian 9
EG - Egitto 9
IL - Israele 9
PE - Perù 8
TN - Tunisia 8
DZ - Algeria 7
EU - Europa 7
LT - Lituania 7
PY - Paraguay 7
SA - Arabia Saudita 7
BG - Bulgaria 6
KG - Kirghizistan 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
BO - Bolivia 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
BY - Bielorussia 4
CY - Cipro 4
GR - Grecia 4
JO - Giordania 4
PA - Panama 4
PS - Palestinian Territory 4
TW - Taiwan 4
ET - Etiopia 3
GA - Gabon 3
GE - Georgia 3
JM - Giamaica 3
LV - Lettonia 3
OM - Oman 3
RS - Serbia 3
AO - Angola 2
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
GD - Grenada 2
HU - Ungheria 2
LB - Libano 2
MD - Moldavia 2
MM - Myanmar 2
NG - Nigeria 2
PT - Portogallo 2
QA - Qatar 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BW - Botswana 1
CG - Congo 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
Totale 21.121
Salva come PNG Salva come JPEG
Città #
Ashburn 1.432
Fairfield 1.130
Singapore 1.105
Chandler 626
Woodbridge 604
Houston 476
Wilmington 471
Ann Arbor 461
San Jose 439
Seattle 439
Hong Kong 429
Cambridge 368
Palermo 299
Moscow 272
Zgierz 205
Los Angeles 182
Council Bluffs 177
New York 175
Beijing 171
Santa Clara 167
Helsinki 159
The Dalles 153
Dublin 147
Medford 145
Tokyo 144
Dallas 140
Ho Chi Minh City 135
Nanjing 118
Des Moines 106
Jacksonville 106
Frankfurt am Main 104
Lauterbourg 98
Rome 97
Altamura 96
Hanoi 95
Princeton 93
Hefei 78
Lawrence 78
Dearborn 70
San Diego 67
Chicago 61
São Paulo 59
Boardman 55
Buffalo 50
Ludwigshafen am Rhein 50
Brussels 47
Orem 45
Jinan 44
London 44
Phoenix 42
Warsaw 42
Tulsa 39
Milan 38
Seoul 37
Nuremberg 35
Shenyang 35
Hebei 34
Denver 33
Bremen 31
Kumar 30
Montreal 29
Munich 29
Tianjin 29
Atlanta 28
Nanchang 27
Brooklyn 26
Kitzingen 26
Abidjan 22
Poplar 22
Venice 22
Amsterdam 21
Changsha 21
Johannesburg 21
Stockholm 21
Guangzhou 20
Rio de Janeiro 20
Chennai 19
Izmir 19
Baghdad 18
Ningbo 18
Toronto 18
Falls Church 17
Haiphong 17
Tashkent 17
Jiaxing 16
San Paolo di Civitate 16
Turku 16
Ankara 15
Boston 15
Brasília 15
Columbus 15
Mumbai 15
Seongnam 15
Hangzhou 14
Pune 14
Saint Petersburg 14
Verona 14
Manchester 13
Vienna 13
Bexley 12
Totale 13.467
Salva come PNG Salva come JPEG
Nome #
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 350
Dietary restriction: could it be considered as speed bump on tumor progression road? 322
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 320
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 319
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 314
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 311
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 305
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 302
Anti-endothelin drugs in solid tumors 296
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 290
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. 288
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 288
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 286
A headlight on liquid biopsies: a challenging tool for breast cancer management 280
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 280
Breast cancer genome-wide association studies: there is strength in numbers 276
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) 269
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 268
BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families. 266
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 266
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 264
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells 263
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 262
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 262
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 261
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 257
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 253
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 250
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 249
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 247
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer 246
The role of Aurora-A inhibitors in cancer therapy. 246
VUS variants in BRCA genes of hereditary breast/ovarian cancer 239
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. 237
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 236
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 235
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) 233
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 233
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 232
TP53, Ki-Ras and P16INK4A gene molecular analysis in salivary gland tumors. 232
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 229
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 225
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) 224
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming 218
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer 217
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway 217
Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma 216
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions 215
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 214
Gene signatures in CRC and liver metastasis 213
BRCA 1/2 VARIANTS OF UNCERTAIN CLINICAL SIGNIFICANCE IN PATIENTS WITH FAMILIAL AND HEREDITARY BREAST/OVARIAN CANCER 211
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer 210
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 210
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 203
Expression level of the mammaglobin (MGB1) gene in BC:possibile index of BC progression 198
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 197
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 197
BRCA1/2 variants of uncertain clinical significance in patients with famlial and hereditary breast/ovarian cancer 195
Non-coding RNAs functioning in colorectal cancer stem cells 192
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? 191
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning 188
Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer 182
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma? 182
Effects of Dietary Restriction on Cancer Development and Progression 179
the proximal leptin gene promoter is regulated by ppar gamma agonist in MCF-7 and MDA-MB-231 breast cancer cells 176
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) 175
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 175
Gists eredo familiari e pediatrici: aspetti biomolecolari e clinici. 174
The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis 173
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 173
MUTYH-associated tumor syndrome: The other face of MAP 172
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? 167
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 165
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes 165
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 162
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 161
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 156
Primary epithelial ovarian neoplasms: New conceptsconcerning origin, pathogenesis and classification based on morphology, immunomarkers, molecular features, and gene expression studies 154
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors 154
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 153
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one? 153
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 153
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 151
Circular RNA in Exosomes 146
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients? 146
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? 145
Liquid Biopsy in Gastrointestinal Stromal Tumor 143
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome 142
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study 141
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 139
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength 137
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? 131
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? 131
Prognostic role of plasma pd‐1, pd‐l1, pan‐btn3as and btn3a1 in patients affected by metastatic gastrointestinal stromal tumors: Can immune checkpoints act as a sentinel for short‐term survival? 129
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 124
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 121
Type and gene location of kit mutations predict progression-free survival to first-line imatinib in gastrointestinal stromal tumors: A look into the exon 121
Scientific Communication and oncology – "The bridge between knowledge and patients" 118
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer 112
role of CML exosomes in the crosstalk between chronic myelogenous leukaemia and bone marrow-derived cells 112
Totale 21.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.114
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021133 0 0 0 0 0 0 0 0 0 0 0 133
2021/20221.335 68 289 47 57 75 60 67 69 126 144 130 203
2022/20231.733 196 343 34 229 192 242 83 128 185 11 58 32
2023/2024972 42 101 53 60 58 212 104 135 6 46 11 144
2024/20252.716 23 225 216 170 140 110 308 245 123 357 338 461
2025/20268.122 724 290 468 711 897 1.319 1.133 816 594 865 282 23
Totale 21.705